Stem cell therapy is an example of regenerative medicine. Stem Cell Therapy delivers a high concentration of a patient’s own stem cells into the injured or weakened area of their body.
Elite athletes, people suffering hair loss and those who experience a lessened quality of life overall due to physical discomfort find treatment through stem cell therapy accelerates healing and reduces pain.
Stem Vita offers treatment with fat derived mesenchymal stem cells
Stem cells are undifferentiated cells with the ability to regenerate and convert into differentiated cells, producing various types of tissues.Adult mesenchymal stem cells (MSCs) can be found in a person’s blood, bone marrow, or adipose tissue (fat). Adipose fat tissue is an abundant source of stem cells. The best quality adipose cells are derived from the use of collagenase to breakdown the extracted fat. Autologous stem cells from a person’s own fat are easy to harvest safely under local anesthesia and on average produce quantities up to 2,500 times those seen in bone marrow. Bone marrow stem cell extractions are quite painful and carry a higher risk of infection.
The higher the number of stem cells, the greater the probability of patient success. Once these adipose derived stem cells are given back into the patient through IV infusion or joint injection, they have the potential to repair damaged human tissue by influencing healing. Examples of these cells are bone, cartilage, nerves, fat, muscle, vessel walls, ligaments, and organ tissue. Stem cells’ ability to form bone and cartilage makes them potentially highly effective in the treatment of degenerative orthopedic conditions. Their ability to form new blood vessels and other tissues makes them suitable for modifying a large number of traumatic and degenerative conditions. In a recent study research showed that Stem Cells from adipose tissue, injected with platelet-rich plasma (PRP), could regenerate cartilage-like tissue in human osteoarthritis (OA) patients.1 Multiple case studies show significant improvement in patient pain and mobility levels after stem cell administration in the joints. Mesenchymal stem cells have resulted in pain and functional improvement in a number of preclinical and clinical trials. Importantly, recent limited case series evidence has shown regrowth of cartilage volume and disease modification following stem cell injections.2 A case series of 339 patients, reporting that of those patients requiring total knee replacement (69 %) only 6.9 % still required replacement surgery after stem cell therapy. Sixty percent of patients reported greater than 50% pain relief and 40% reported >75 % pain relief at 11 months.3 Base on this clinical data, we believe in offering stem cell therapy to minimize the need for surgical intervention in Osteoarthritic patients.
Email us on firstname.lastname@example.org or call us on +44 01789 414203.